Cantel Medical Corp. (CMN) Reports In-Line Q3 EPS of 33c

Cantel Medical Corp. (NYSE: CMN) reported Q3 EPS of $0.33, in-line with the analyst estimate of $0.33. Revenue for the quarter came in at $105.01 million versus the consensus estimate of $104.92 million.

For earnings history and earnings-related data on Cantel Medical Corp. (CMN) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Is the global equity rally broadening? UBS weighs in
• Baird Starts Jersey Mike's Subs (JMKE) at Outperform
• Barclays Downgrades Merlin Properties SA (MRL:SM) (MRPRF) to Equalweight